Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
BMC Cancer|December 18, 2014
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancerJavier Martinez-Useros, Maria Rodriguez-Remirez, Aurea Borrero-Palacios, et al.
Molecular Oncology|June 15, 2019
Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunctionLaura Del Puerto-Nevado, Aranzazu Santiago-Hernandez, Sonia Solanes-Casado, et al.
International Journal of Colorectal Disease|May 9, 2015
MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancerCristina Caramés, Ion Cristóbal, Víctor Moreno, et al.
The FEBS Journal|July 16, 2019
Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoidsAsunción Fernández-Barral, Alba Costales-Carrera, Sandra P Buira, et al.
Plos One|March 3, 2017
Colon cancer modulation by a diabetic environment: A single institutional experienceIsabel Prieto, Laura Del Puerto-Nevado, Nieves Gonzalez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal AdenocarcinomaMarie E Robert, Josef Rüschoff, Bharat Jasani, et al.
Molecular Diagnosis & Therapy|June 17, 2026
Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid BiopsyFederico Rojo, Valentina Guarneri, Nicola Fusco, et al.
Breast Cancer Research and Treatment|August 8, 2019
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastasesZhe-Bin Liu, Nader E Ezzedine, Agda K Eterovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2021
Preclinical and Clinical Characterization of Fibroblast-derived Neuregulin-1 on Trastuzumab and Pertuzumab Activity in HER2-positive Breast CancerCristina Guardia, Giampaolo Bianchini, Oriol Arpí-LLucià, et al.
Cancers|May 6, 2020
The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast CancerPaula González-Alonso, Sandra Zazo, Ester Martín-Aparicio, et al.
Pageof 23